AI-guided treatment planning for esophageal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial uses artificial intelligence to create a digital twin of your cancer and simulate how it might respond to different treatments. The goal is to find the best treatment plan for you before you start therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer that has not spread beyond the chest and have not yet received any treatment for it.
- You are generally healthy enough for surgery, with no major heart, lung, or bleeding problems.
- Your blood counts and liver/kidney function are within acceptable ranges.
- You have not had chemotherapy, radiation, or immunotherapy for this cancer before.
- You are willing to use effective birth control during the study and for 6 months after, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a blood test to find tiny bits of tumor DNA after surgery. If the test is positive, you may receive additional therapy to lower the risk of cancer coming back.
This trial tests a drug called Toripalimab given after surgery for esophageal cancer to see if it helps prevent the cancer from coming back. It's for people who already had chemotherapy and immunotherapy before surgery and had all the cancer removed.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
This trial tests a precision medicine approach for people with advanced esophageal cancer that has stopped responding to immunotherapy. The goal is to find better treatments based on each person's tumor biology.
This trial tests if a personalized treatment plan based on specific markers from your tumor can work better than standard chemotherapy for advanced esophageal cancer that has spread. It aims to find the best first treatment for your cancer type.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.